查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
居家睡眠呼吸中止設備市場：2023年至2028年預測
市場調查報告書
商品編碼
1410139

居家睡眠呼吸中止設備市場：2023年至2028年預測

Home-Based Sleep Apnea Devices Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

家庭睡眠呼吸中止設備市場預計將從2021年的15.56億美元成長到2028年的45.23億美元，複合年成長率為16.47%。

近年來，由於睡眠呼吸中止症的盛行率不斷增加以及人們對其潛在健康危害的認知不斷增強，家庭睡眠呼吸中止設備市場顯著成長。這些最尖端科技提供了一種簡單、非侵入性的方法，讓您可以在舒適的家中監測和診斷睡眠呼吸中止。透過利用氣流感測器、脈搏血氧計和穿戴式裝置等創新技術，這些家用系統可以正確檢測睡眠障礙，並向醫療保健專業人員提供關鍵資料。對遠端患者監測和遠端醫療的日益重視正在推動對此類設備的需求，為睡眠呼吸中止護理提供具有成本效益且易於使用的選擇。隨著全球人口尋求更好的睡眠，家庭睡眠呼吸中止設備市場預計將在未來幾年穩步擴大。

睡眠呼吸中止症盛行率的上升正在推動家庭睡眠呼吸中止設備市場的成長。

睡眠呼吸中止症盛行率的增加是家庭睡眠呼吸中止設備市場的主要成長要素。世界上很大一部分人口患有睡眠呼吸中止，這是一種以睡眠期間呼吸問題為特徵的睡眠障礙。生活方式的改變、肥胖、人口老化以及人們對睡眠問題的認知不斷提高，導致這種疾病的盛行率不斷上升。因此，對有效且方便的家用設備的需求不斷成長，這些設備可以監測和診斷睡眠呼吸中止，使人們能夠在舒適的家中管理自己的疾病。開拓和醫療保健提供者正在積極投資此類設備的開發和行銷，以滿足不斷成長的患者需求，並減輕睡眠呼吸中止中止症對公共衛生系統日益嚴重的影響。

睡眠呼吸中止設備的技術進步。

家用睡眠呼吸中止設備技術的開拓是市場擴張的主要因素。這些進步導致了更複雜和更易於使用的設備的開發，使個人更容易控制睡眠呼吸中止。先進的感測器和演算法現在可以準確、即時地監測您的睡眠模式、呼吸事件和氧氣水平。此外，小型化和穿戴式技術使這些小工具更加舒適和攜帶，讓用戶安心入睡。與智慧型手機和其他智慧型裝置的整合可實現平穩的資料傳輸和分析，為患者和醫療保健專業人員提供個人化治療計劃的寶貴見解。隨著技術的進步，家庭睡眠呼吸中止設備市場預計將進一步開拓，改善患者的治療效果並促進睡眠健康。

便利性和非侵入式監控推動了家庭睡眠呼吸中止設備的市場規模。

家用睡眠呼吸中止設備的易用性和非侵入式監測對其接受度和市場擴張發揮關鍵作用。與傳統的實驗室睡眠研究不同，這些小工具可以追蹤睡眠模式和呼吸事件，同時保護個人隱私。這種非侵入性方法無需在睡眠中心住宿，從而減輕疼痛並促進改善睡眠品質。使用者可以穿戴穿戴式裝置或連接非侵入式感測器，從而省去了設定標準睡眠監測設備的麻煩。將這些設備融入日常生活中可以實現連續、不引人注目的資料收集，使患者和醫療保健提供者能夠評估睡眠品質、檢測睡眠障礙和個人化治療。它為規劃提供了寶貴的見解，最終提高了患者的依從性和整體睡眠健康狀況。

北美是家庭睡眠呼吸中止市場的市場領導者。

北美是家庭睡眠呼吸中止市場的市場領導者。這是由於許多變數造成的，包括該地區睡眠呼吸中止中止症的高盛行率、完善的醫療基礎設施以及公眾對睡眠障礙的認知提高。此外，技術的重大進步和有利的法規環境正在支持北美家庭睡眠呼吸中止設備的採用。重要市場參與者的存在、研發工作以及先進穿戴式技術的可用性鞏固了該地區作為推動家庭睡眠呼吸中止設備市場創新和成長的先驅者的地位。

家庭睡眠呼吸中止設備市場對持續睡眠健康監測的需求。

人們越來越認知到睡眠對整體健康的重要性，這增加了對持續睡眠健康監測的需求。隨著人們越來越意識到睡眠對其身心健康的影響，他們正在尋求技術來監測他們的睡眠習慣並識別潛在的睡眠問題。持續的睡眠健康監測可以持續評估睡眠品質、呼吸事件和睡眠相關指標，從而提供個人睡眠健康狀況的整體情況。家用睡眠呼吸中止設備和穿戴式技術提供持續監測，使用戶能夠分析他們的睡眠模式、識別睡眠中斷並做出明智的決定來改善他們的睡眠習慣。此外，醫療保健提供者將能夠存取縱向資料，從而實現更準確的診斷、個人化治療以及對睡眠相關疾病的主動管理，從而改善患者的治療結果。

主要進展：

2023年6月，世界醫療技術先驅皇家飛利浦與全球醫療技術營運商Masimo宣布，飛利浦患者監護儀Intelliview MX750和MX850將配備Sedline腦功能監測、局部血氧飽和度和CO2測量功能。它已獲得FDA 批准。 Masimo 和飛利浦持續合作的最新進展將幫助醫生做出更快、更明智的決策，而無需額外的監測設備。 2022 年 7 月，內特斯醫療公司（Natus Medical Incorporated）是一家領先的醫療設備解決方案提供商，篩檢篩檢、診斷和治療影響大腦、神經途徑和八種感覺神經系統的疾病，宣布了一項專門針對醫療保健行業的重大投資。已被 ArchiMed 的 MED Platform II 基金收購。根據最終合併協議，Natus 股東每股 Natus 普通股可獲得 33.50 美元現金。

公司產品

  • CPAP 機： ResMed 因其阻塞型睡眠呼吸中止症聞名。這些設備提供恆定的氣流通過面罩，讓您在睡眠時保持呼吸道暢通並防止呼吸中止。
  • 自動 CPAP (APAP) 機：飛利浦偉康提供的自動調節 CPAP 機可根據患者夜間的呼吸模式自動改變氣壓水平，確保最佳治療和舒適度。
  • 雙水平陽壓呼吸器(BiPAP) 設備： Drive DeVilbiss Healthcare 推出了 BiPAP 設備，可在吸氣和呼氣期間提供兩個獨立的氣壓等級。該設備適合患有更複雜的睡眠呼吸中止或需要更高壓力支持的人。
  • CPAP 面罩和配件BMC Medical Co., Ltd. 提供各種 CPAP 面罩，包括鼻罩、鼻枕和全面罩，以及管子、過濾器和加濕器等配件，以提高治療過程中的舒適度和依從性。我們提供

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 資訊來源
  • 研究設計

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 業內競爭對手之間的對抗關係
  • 產業價值鏈分析

第5章家用睡眠呼吸中止設備市場：依設備類型

  • 介紹
  • 正壓呼吸器(PAP)設備
  • 持續性陽壓呼吸器(CPAP) 裝置
  • 雙水平陽壓呼吸器(BIPAP) 裝置
  • 口腔矯正器
  • 自我調整伺服通氣 (ASV) 裝置
  • 氧氣設備
  • 其他

第6章家用睡眠呼吸中止設備市場：依應用分類

  • 介紹
  • 手動的
  • 自動的

第 7 章 家用睡眠呼吸中止設備市場：依最終用戶分類

  • 介紹
  • 醫院及睡眠診所
  • 家庭護理設置
  • 睡眠中心
  • 其他
  • 家用睡眠呼吸中止設備市場：按地區
  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 台灣
    • 其他

第8章競爭環境及分析

  • 主要企業及策略分析
  • 新興企業和市場盈利
  • 合併、收購、協議和合作
  • 供應商競爭力矩陣

第9章 公司簡介

  • RESMED INC.
  • KONINKLIJKE PHILIPS NV
  • FISHER & PAYKEL HEALTHCARE LIMITED
  • INVACARE CORPORATION
  • DRIVE DEVILBISS HEALTHCARE
  • BMC MEDICAL CO., LTD.
  • COMPUMEDICS LIMITED
  • NATUS MEDICAL INCORPORATED
  • NIHON KOHDEN CORPORATION
  • APEX MEDICAL CORP.
簡介目錄
Product Code: KSI061615809

The home-based sleep apnea devices market is expected to grow at a CAGR of 16.47% from US$1.556 billion in 2021 to US$4.523 billion in 2028.

The home-based sleep apnea devices market has grown significantly in recent years, owing to the increasing prevalence of sleep apnea and greater awareness of its potential health hazards. These cutting-edge technologies provide a simple and non-intrusive way to monitor and diagnose sleep apnea from the comfort of one's own home. These home-based systems can correctly detect sleep disorders and give vital data to healthcare experts by utilising innovative technology such as airflow sensors, pulse oximetry, and wearable gadgets. The growing emphasis on remote patient monitoring and telemedicine has spurred demand for such devices, which provide cost-effective and accessible options for sleep apnea care. As the worldwide population strives for better sleep health, the home-based sleep apnea devices market is expected to expand steadily in the coming years.

Rising Prevalence of Sleep Apnea Enhances the Home-Based Sleep Apnea Devices Market Growth.

The increased prevalence of sleep apnea is a major growth factor in the home-based sleep apnea devices market. A significant proportion of the worldwide population suffers from sleep apnea, a sleep disease characterised by disrupted breathing during sleep. Lifestyle changes, obesity, ageing demographics, and more awareness of sleep problems all contribute to the condition's rising incidence. As a result, there is a rising desire for effective and convenient home-based devices that can monitor and diagnose sleep apnea, allowing people to manage their disease from the convenience of their own homes. Manufacturers and healthcare providers are aggressively investing in developing and marketing such devices in order to meet patients' expanding requirements and alleviate the growing impact of sleep apnea on public health systems.

Technological Advancements in Home-Based Devices in Home-Based Sleep Apnea Devices Market.

Technological developments in home-based sleep apnea devices have been a major driver of market expansion. These advancements have resulted in the creation of more complex and user-friendly devices, making it easier for individuals to control their sleep apnea. Sleep patterns, respiratory events, and oxygen levels may all be monitored accurately and in real time thanks to advanced sensors and algorithms. Furthermore, miniaturisation and wearable technologies have increased the comfort and portability of these gadgets, allowing users to sleep peacefully with them. Integration with smartphones and other smart devices provides smooth data transfer and analysis, providing useful insights to patients and healthcare professionals for personalised treatment programmes. As technology advances, the home-based sleep apnea devices market is projected to see more developments, improving patient outcomes, and encouraging improved sleep health.

Convenience and Non-Intrusive Monitoring Boosts the Home-Based Sleep Apnea Devices Market Size.

The ease of use and non-intrusive monitoring provided by home-based sleep apnea devices have played an important part in their acceptance and market expansion. These gadgets, unlike traditional in-lab sleep studies, allow individuals to track their sleep patterns and respiratory episodes in the privacy of their own homes. This non-intrusive method removes the need for overnight stays in sleep centres, which reduces pain and promotes improved sleep quality. Users can easily wear wearable devices or put non-invasive sensors, eliminating the need for the time-consuming setup of standard sleep monitoring equipment. The incorporation of these devices into daily routines allows for continuous and unobtrusive data collection, providing valuable insights for both patients and healthcare providers to assess sleep quality, detect sleep disorders, and design personalised treatment plans, ultimately improving patient compliance and overall sleep health.

North America is the Market Leader in the Home-Based Sleep Apnea Devices Market.

North America was regarded as the market leader in the home-based sleep apnea devices market. This can be ascribed to a number of variables, including the region's high prevalence of sleep apnea, a well-established healthcare infrastructure, and rising public awareness of sleep disorders. Furthermore, major technology improvements and a favourable regulatory environment in North America have encouraged the introduction of home-based sleep apnea devices. The presence of significant market players, R&D efforts, and the availability of advanced wearable technologies strengthened the region's position as a trailblazer in driving innovations and growth in the home-based sleep apnea devices market.

Demand for Continuous Sleep Health Monitoring in Home-Based Sleep Apnea Devices Market.

The growing acknowledgment of the importance of sleep-in overall well-being is driving the increased need for continuous sleep health monitoring. Individuals are looking for techniques to monitor their sleep habits and identify potential sleep problems as awareness about the influence of sleep on physical and mental health grows. Continuous sleep health monitoring enables for continuous evaluation of sleep quality, respiratory events, and sleep-related indicators, offering a full picture of an individual's sleep health throughout time. Continuous monitoring is provided through home-based sleep apnea devices and wearable technology, allowing users to analyse their sleep patterns, identify sleep interruptions, and make educated decisions to improve their sleep habits. Furthermore, healthcare providers will have access to longitudinal data, which will allow for more accurate diagnosis, personalised therapy, and proactive management of sleep-related illnesses for better patient outcomes.

Key Developments:

  • In June 2023, Royal Philips, a worldwide pioneer in health technology, and Masimo, a global medical technology business, announced today that SedLine Brain Function Monitoring, Regional Oximetry, and CO2 readings in Philips Patient Monitors - IntelliVue MX750 and MX850 - have received FDA clearance. The latest development in Masimo and Philips' continuous partnership will assist physicians in making rapid and informed judgements without the need for extra monitoring equipment.
  • In July 2022, Natus Medical Incorporated, a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems, announced that it had been acquired by ArchiMed's MED Platform II fund, a leading investment firm focused solely on the healthcare industry. Natus stockholders received $33.50 in cash for each share of Natus common stock, according to the official merger agreement.

Company Products:

  • CPAP Machines: ResMed is well-known for its continuous positive airway pressure (CPAP) devices, which are commonly used to treat obstructive sleep apnea (OSA). These devices provide a constant flow of air through a mask, keeping the airway open during sleep and preventing breathing pauses.
  • Auto-CPAP (APAP) Machines: Philips Respironics offered auto-adjusting CPAP devices, which automatically alter air pressure levels based on the patient's breathing patterns during the night, assuring optimal treatment and comfort.
  • Bi-Level Positive Airway Pressure (BiPAP) Machines: Drive DeVilbiss Healthcare introduced BiPAP devices, which give two separate air pressure levels during inhalation and exhalation. These devices are appropriate for people with more complicated sleep apnea disorders or requiring higher-pressure assistance.
  • CPAP Masks and Accessories: BMC Medical Co., Ltd. offers a wide range of CPAP masks, including nasal masks, nasal pillows, and full-face masks, as well as accessories like as tubing, filters, and humidifiers to improve comfort and compliance during therapy.

Segmentation:

By Type Of Device

  • Positive Airway Pressure (Pap) Devices
  • Continuous Positive Airway Pressure (Cpap) Devices
  • Bi-Level Positive Airway Pressure (Bipap) Devices
  • Oral Appliances
  • Adaptive Servo-Ventilation (Asv) Devices
  • Oxygen Devices
  • Others

By Application

  • Manual
  • Automatic

By End-User

  • Hospitals And Sleep Clinics
  • Home Care Settings
  • Sleep Centers
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Sources
  • 2.3. Research Design

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. HOME-BASED SLEEP APNEA DEVICES MARKET, BY TYPE OF DEVICE

  • 5.1. Introduction
  • 5.2. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
  • 5.3. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
  • 5.4. BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES
  • 5.5. ORAL APPLIANCES
  • 5.6. ADAPTIVE SERVO-VENTILATION (ASV) DEVICES
  • 5.7. OXYGEN DEVICES
  • 5.8. OTHERS

6. HOME-BASED SLEEP APNEA DEVICES MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. MANUAL
  • 6.3. AUTOMATIC

7. HOME-BASED SLEEP APNEA DEVICES MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. HOSPITALS AND SLEEP CLINICS
  • 7.3. HOME CARE SETTINGS
  • 7.4. SLEEP CENTERS
  • 7.5. OTHERS
  • 7.6. HOME-BASED SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY
  • 7.7. Introduction
  • 7.8. North America
    • 7.8.1. United States
    • 7.8.2. Canada
    • 7.8.3. Mexico
  • 7.9. South America
    • 7.9.1. Brazil
    • 7.9.2. Argentina
    • 7.9.3. Others
  • 7.10. Europe
    • 7.10.1. United Kingdom
    • 7.10.2. Germany
    • 7.10.3. France
    • 7.10.4. Italy
    • 7.10.5. Spain
    • 7.10.6. Others
  • 7.11. Middle East and Africa
    • 7.11.1. Saudi Arabia
    • 7.11.2. UAE
    • 7.11.3. Others
  • 7.12. Asia Pacific
    • 7.12.1. Japan
    • 7.12.2. China
    • 7.12.3. India
    • 7.12.4. South Korea
    • 7.12.5. Indonesia
    • 7.12.6. Taiwan
    • 7.12.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

  • 9.1. RESMED INC.
  • 9.2. KONINKLIJKE PHILIPS N.V.
  • 9.3. FISHER & PAYKEL HEALTHCARE LIMITED
  • 9.4. INVACARE CORPORATION
  • 9.5. DRIVE DEVILBISS HEALTHCARE
  • 9.6. BMC MEDICAL CO., LTD.
  • 9.7. COMPUMEDICS LIMITED
  • 9.8. NATUS MEDICAL INCORPORATED
  • 9.9. NIHON KOHDEN CORPORATION
  • 9.10. APEX MEDICAL CORP.